PSA Response and Treatment Adherence to Apalutamide in Patients With Nonmetastatic CRPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Urology 2022 Mar 19;[EPub Ahead of Print], B Lowentritt, G Brown, D Pilon, L Ellis, G Germain, C Rossi, P Lefebvre, K Kernen, P Sieber, N ShoreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.